Biofarm Cash Flow Statement

Financials in millions RON. Fiscal year is January - December.

Millions RON. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	74.4	77.01	70.92	60.36
Depreciation & Amortization	17.03	16.96	15.5	13.73
Loss (Gain) From Sale of Assets	-0.16	-0.31	-0.05	-0.21
Asset Writedown & Restructuring Costs	-0.13	-2.78	-1.92	-0.39
Provision & Write-off of Bad Debts	-	-1.72	-0.06	-
Other Operating Activities	-2.56	-11.05	-2.82	-3.56
Change in Accounts Receivable	-46.37	30.8	-24.58	-3.3
Change in Inventory	2.22	-1.65	-29.76	3.43
Change in Other Net Operating Assets	13.17	-27.43	1.79	-0.87
Operating Cash Flow	57.59	79.83	29.02	69.18
Operating Cash Flow Growth	-27.86%	175.10%	-58.06%	75.10%
Capital Expenditures	-23.41	-29.84	-30.13	-21.45
Sale of Property, Plant & Equipment	0.17	0.32	0.05	0.4
Investment in Securities	29	-91	-	21
Other Investing Activities	7.03	6.88	2.46	0.88
Investing Cash Flow	12.78	-113.64	-27.62	0.83
Common Dividends Paid	-29.19	-28.24	-22.55	-20.69
Financing Cash Flow	-29.19	-28.24	-22.55	-20.69
Net Cash Flow	41.18	-62.05	-21.15	49.32
Free Cash Flow	34.18	49.99	-1.11	47.73
Free Cash Flow Growth	-31.63%	-	-	297.13%
Free Cash Flow Margin	11.92%	17.83%	-0.40%	19.97%
Free Cash Flow Per Share	0.03	0.05	-0.00	0.04
Cash Interest Paid	-	-	-	0
Cash Income Tax Paid	11.51	9.25	14.63	13.74
Levered Free Cash Flow	18.5	36.03	-21.12	40.47
Unlevered Free Cash Flow	18.5	36.03	-21.12	40.47
Change in Working Capital	-30.97	1.72	-52.55	-0.75

Source: S&P Global Market Intelligence. Standard template. Financial Sources.